Bone Metastases News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Cabozantinib Improves Survival in RCC Patients With Bone Metastases - OncLive



OncLive
 
Cabozantinib Improves Survival in RCC Patients With Bone Metastases 
OncLive
Cabozantinib (Cabometyx) was associated with an 8-month improvement in overall survival (OS) and a 4.7-month improvement in progression-free survival (PFS) compared with everolimus (Afinitor) in pretreated patients with advanced renal cell carcinoma ...

and more » 


Model Stratifies Long Bone Metastases Pts By Survival - Renal and Urology News



Renal and Urology News
 
Model Stratifies Long Bone Metastases Pts By Survival 
Renal and Urology News
(HealthDay News) -- A model with 4 categories has been developed to stratify patients with symptomatic long bone metastases (LBM) based on their expected survival, according to an article published online in the Journal of Bone & Joint Surgery. Julie J ...

 


Osteomimicry May Contribute to Uptake of Radium-223 Within Bone Metastases for Patients With mCRPC - AJMC.com Managed Markets Network



Osteomimicry May Contribute to Uptake of Radium-223 Within Bone Metastases for Patients With mCRPC 
AJMC.com Managed Markets Network
Osteomimicry may contribute to the uptake of radium-223 within bone metastases and may subsequently enhance the therapeutic benefit of radium-223, according to an abstract presented by Andrew Armstrong, MD, associate professor of medicine, Duke ...
ASCO GU 2018: Genomic and Phenotypic Evidence for Prostate Cancer Osteomimicry in Circulating Tumor Cells from ... UroToday

all 2 news articles » 


Cabozantinib Superior to Everolimus in Treatment of RCC Patients With Bone Metastases - Targeted Oncology



Targeted Oncology
 
Cabozantinib Superior to Everolimus in Treatment of RCC Patients With Bone Metastases 
Targeted Oncology
According to results of a subgroup analysis of the phase III METEOR trial, cabozantinib (Cabometyx) demonstrated a 4.7 month improvement in progression-free survival (PFS) compared with everolimus (Afinitor) in pretreated patients with advanced renal ...

 


Simple tool can help doctors estimate survival for patients with long bone metastases - News-Medical.net



News-Medical.net
 
Simple tool can help doctors estimate survival for patients with long bone metastases 
News-Medical.net
A simple three-factor tool can help doctors estimate survival time in patients with long bone metastases (LBMs)- advanced cancer that has spread to the bones of the limbs, reports a study in the February 7, 2018, issue of The Journal of Bone & Joint ...

 


3 new FDA drug approvals - ModernMedicine



3 new FDA drug approvals 
ModernMedicine
?The need to delay metastasis is critical to the treatment of prostate cancer. Nearly 90% of patients with castration-resistant prostate cancer will eventually develop bone metastases, at which point the prognosis sharply worsens,? said Mathai Mammen ...

 


Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the ... - UroToday



Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the ... 
UroToday
Bone metastases commonly occur in conjunction with solid tumors, and are associated with serious bone complications. Population-based estimates of bone metastasis incidence are limited, often based on autopsy data, and may not reflect current treatment ...

 


The relationship between local recurrences and distant metastases in prostate cancer: can11C-choline PET/CT ... - UroToday



The relationship between local recurrences and distant metastases in prostate cancer: can11C-choline PET/CT ... 
UroToday
On the contrary, the frequency of lymph node metastases (overall rate in the 0-16 years interval after prostatectomy: 26.3%) and of bone metastases (overall rate: 13.8%) decreased significantly over time. Kaplan-Meier curves showed no significant group ...

 


Bone Markers Can Predict Bone-Specific Recurrence in Early Breast Cancer - Cancer Network



Bone Markers Can Predict Bone-Specific Recurrence in Early Breast Cancer 
Cancer Network
Several markers of bone formation and resorption were found to be predictive of bone-specific recurrence in patients with early breast cancer, according to a new study. ?Bone metastases ultimately affect more than two-thirds of patients with advanced ...

 


Maintaining Bone Health During ADT for Prostate Cancer - OncLive



OncLive
 
Maintaining Bone Health During ADT for Prostate Cancer 
OncLive
As a clinician assesses whether a patient should initiate ADT, there are appropriate minimal steps to take to address bone health. First, obtain a bone health history, including assessing loss in height as an indicator of prior vertebral compression ...